methimazole and Lung-Diseases

methimazole has been researched along with Lung-Diseases* in 5 studies

Other Studies

5 other study(ies) available for methimazole and Lung-Diseases

ArticleYear
Methimazole-induced antineutrophil cytoplasmic antibody-associated diffuse alveolar haemorrhage in a Chinese woman with Graves' disease.
    Hong Kong medical journal = Xianggang yi xue za zhi, 2009, Volume: 15, Issue:3

    We report on a case of diffuse alveolar haemorrhage in a Chinese woman due to methimazole-induced antineutrophil cytoplasmic antibodies. A literature search for anti-thyroid drugs associated with antineutrophil cytoplasmic antibody-induced diffuse alveolar haemorrhages is reviewed. Diffuse alveolar haemorrhage is a rare complication of thiourea agents and the treatment often requires corticosteroids or other immunosuppressants, together with withdrawal of the causative agent.

    Topics: Adult; Antibodies, Antineutrophil Cytoplasmic; Antithyroid Agents; Comorbidity; Female; Graves Disease; Hemorrhage; Humans; Lung Diseases; Methimazole; Pulmonary Alveoli; Vasculitis

2009
Methimazole protects lungs during hepatic ischemia-reperfusion injury in rats: an effect not induced by hypothyroidism.
    Journal of gastroenterology and hepatology, 2007, Volume: 22, Issue:5

    Hepatic ischemia-reperfusion injury may lead to remote organ failure with mortal respiratory dysfunction. The aim of the present study was to analyze the possible protective effects of methimazole on lungs after hepatic ischemia-reperfusion injury.. Forty male Wistar albino rats were randomized into five groups: a control group, in which bilateral pulmonary lobectomy was done; a hepatic ischemia-reperfusion group, in which bilateral pulmonary lobectomy was done after hepatic ischemia-reperfusion; a thyroidectomy-ischemia-reperfusion group (total thyroidectomy followed by, 7 days later, bilateral pulmonary lobectomy after hepatic ischemia-reperfusion); a methimazole-ischemia-reperfusion group (following methimazole administration for 7 days, bilateral pulmonary lobectomy was done after hepatic ischemia-reperfusion); and a methimazole +L-thyroxine-ischemia-reperfusion group (following methimazole and L-thyroxine administration for 7 days, bilateral pulmonary lobectomy was performed after hepatic ischemia-reperfusion). Pulmonary tissue specimens were evaluated histopathologically and for myeloperoxidase and malondialdehyde levels.. All of the ischemia-reperfusion intervention groups had higher pulmonary injury scoring indices than the control group (P < 0.001). Pulmonary injury index of the ischemia-reperfusion group was higher than that of both the methimazole-supplemented hypothyroid and euthyroid groups (P = 0028; P = 0,038, respectively) and was similar to that of the thyroidectomized group. Pulmonary tissue myeloperoxidase and malondialdehyde levels in the ischemia-reperfusion group were similar with that in the thyroidectomized rats but were significantly higher than that in the control, and both the methimazole-supplemented hypothyroid and euthyroid groups.. Methimazole exerts a protective role on lungs during hepatic ischemia-reperfusion injury, which can be attributed to its anti-inflammatory and anti-oxidant effects rather than hypothyroidism alone.

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Antithyroid Agents; Disease Models, Animal; Hepatic Artery; Liver; Lung; Lung Diseases; Male; Malondialdehyde; Methimazole; Peroxidase; Pneumonectomy; Portal Vein; Rats; Rats, Wistar; Reperfusion Injury; Thyroidectomy; Thyroxine

2007
Methimazole-induced pulmonary hemorrhage associated with antimyeloperoxidase-antineutrophil cytoplasmic antibody: a case report.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2001, Volume: 100, Issue:11

    Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis has been recently recognized in Graves' disease patients treated with antithyroid drugs. We describe the case of an 18-year-old girl who developed antimyeloperoxidase ANCA (MPO-ANCA)-positive vasculitis manifesting as a skin lesion and hemoptysis with hypoxic respiratory failure after taking methimazole. An open lung biopsy was consistent with acute capillaritis. Both skin and sural nerve biopsy showed lymphocytic vasculitis. Administration of steroid and plasmapheresis produced a good clinical response.

    Topics: Adolescent; Antibodies, Antineutrophil Cytoplasmic; Antithyroid Agents; Autoantibodies; Female; Hemorrhage; Humans; Lung Diseases; Methimazole; Peroxidase; Skin Diseases, Vascular; Vasculitis

2001
What is your diagnosis? Chronic fibrosing pleuritis, pleural effusion, and lobar consolidation.
    Journal of the American Veterinary Medical Association, 2000, May-15, Volume: 216, Issue:10

    Topics: Animals; Antithyroid Agents; Cat Diseases; Cats; Diagnosis, Differential; Fatal Outcome; Hydrothorax; Hyperthyroidism; Lung Diseases; Male; Methimazole; Pleural Diseases; Radiography, Thoracic; Torsion Abnormality

2000
[Mercazolil in treatment of patients with chronic pulmonary insufficiency].
    Vrachebnoe delo, 1978, Issue:5

    Topics: Adult; Aged; Bronchitis; Chronic Disease; Female; Humans; Lung Diseases; Male; Methimazole; Middle Aged; Pneumonia

1978